ICD-10 Coding for Metastatic Ovarian Cancer(C48.2P, C56.1, C56.1B)

Comprehensive guide on ICD-10 coding for metastatic ovarian cancer, including primary and secondary codes, documentation requirements, and common pitfalls.

Also known as:
Ovarian Cancer with MetastasisSecondary Ovarian Cancer
Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Ovarian Cancer

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C56.1Malignant neoplasm of right ovary
C56.2Malignant neoplasm of left ovary
C56.3Malignant neoplasm of bilateral ovaries
C78.6Secondary malignant neoplasm of retroperitoneum and peritoneum

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutMetastatic Ovarian Cancer

Differential Codes

Alternative codes to consider when ruling out similar conditions

Benign neoplasm of ovaryD27.0
Malignant neoplasm of peritoneumC48.2

Documentation & Coding Risks

Avoid these common issues when documenting Metastatic Ovarian Cancer.

Failing to document metastatic sites

Impact

Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.

Mitigation

Ensure all metastatic sites are documented in clinical notes.

Using unspecified codes when laterality is known

Impact

Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.

Mitigation

Document and code the specific laterality (right, left, bilateral).

Use of unspecified codes

Impact

High risk of audits when unspecified codes are used despite available specificity.

Mitigation

Ensure documentation supports the most specific code available.

Frequently Asked Questions